Contents

Search


linear IgA disease

Pathology: - subepidermal blistering disorder - tissue-bound & circulating IgA autoantibodies to the dermal-epidermal junction - both the 120 kD linear IgA disease antigen & the 97 kD linear IgA disease antigen of COL17A1, represent major antigenic targets of autoantibodies in patients with linear IgA disease - the IgA autoantibodies preferentially react with 97 kD & the 120 kD forms, but not with the full-length COL17A1, suggesting that the cleavage of the ectodomain generates novel autoantigenic epitopes Laboratory: - see ARUP consult [2]

General

vesiculobullous dermatitis

References

  1. UniProt :accession Q9UMD9
  2. ARUP Consult: Linear IgA Disease The Physician's Guide to Laboratory Test Selection & Interpretation https://www.arupconsult.com/content/linear-iga-disease
  3. Chaudhari S, Mobini N. Linear IgA Bullous Dermatosis: A Rare Clinicopathologic Entity with an Unusual Presentation. J Clin Aesthet Dermatol. 2015 Oct;8(10):43-6. PMID: 26557220 Free PMC Article
  4. Chen S, Mattei P, Fischer M, Gay JD, Milner SM, Price LA. Linear IgA bullous dermatosis. Eplasty. 2013 Jul 2;13:ic49. Print 2013. PMID: 23882302 Free PMC Article
  5. Haeberle MT, James WD Linear IgA Dermatosis Medscape: (eMedicine) https://emedicine.medscape.com/article/1063590-overview